BioNexus Gene Lab Corp BGLC 深 沪
等待开盘 02-07 09:30:00 美东时间
2.11
+0.120
+6.03%
华盛通- 最 高4.23
- 今 开2.02
- 成交量 7006股
- 最 低 1.976
- 昨 收 1.99
- 总市值 36.13万
- 52周最高 15.60
- 市盈率 静 479.55
- 换手率 0.00%
- 52周最低 0.2262
- 委 比 99.64%
- 总股本 0.00亿
- 历史最高 15.60
- 量 比 0.31
- 振 幅 113.27%
- 历史最低 0.20
- 每 手 1
- 风险率 1.89%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多BioNexus Gene Lab Names Matthew L. Barsing As Chairman Of The Board
As previously disclosed, commencing in the third quarter of fiscal year 2025, the Company's Board of Directors authorized the evaluation of a potential expansion into Contract Development and Manufacturing ("CDMO")
2025-12-24 06:37
中北能盘中异动 下午盘急速拉升5.04%报0.296美元
北京时间2025年01月17日03时08分，中北能（CNEY.us）股票出现波动，股价急速上涨5.04%。截至发稿，该股报0.296美元/股，成交量38.1233万股，换手率5.51%，振幅7.45%。 最近的财报数据显示，该股实现营业收入31.29百万美元，净利润-2.96百万美元，每股收益-1.64美元，毛利65392.00美元，市盈率-0.06倍。 机构评级方面，目前暂无机构对该股做出“买入、持有、卖出”建议。 中北能股票所在的化学制品行业中，整体涨幅为0.99%。其相关个股中，Flexible Solutions International Inc.、Crown Electrokine...
2025-01-17 03:08
奎克化学盘中异动 临近收盘股价大跌5.02%
北京时间2025年01月11日04时33分，奎克化学（KWR.us）股票出现异动，股价快速下跌5.02%。截至发稿，该股报124.66美元/股，成交量10.0772万股，换手率0.57%，振幅4.09%。 最近的财报数据显示，该股实现营业收入4.62亿美元，净利润32.26百万美元，每股收益1.81美元，毛利1.58亿美元，市盈率18.35倍。 机构评级方面，在所有6家参与评级的机构中，67%的券商给予买入建议，33%的券商给予持有建议，无券商给予卖出建议。 奎克化学股票所在的化学制品行业中，整体跌幅为0.57%。其相关个股中，南非萨索尔、Perimeter Solutions, Sa、Fle...
2025-01-11 04:33
智利矿业化工盘中异动 股价大涨5.04%报38.55美元
北京时间2025年01月07日02时47分，智利矿业化工（SQM.us）股票出现异动，股价大幅拉升5.04%。截至发稿，该股报38.55美元/股，成交量98.174万股，换手率0.34%，振幅2.53%。 最近的财报数据显示，该股实现营业收入10.77亿美元，净利润1.31亿美元，每股收益0.46美元，毛利2.75亿美元，市盈率-34.20倍。 机构评级方面，在所有17家参与评级的机构中，65%的券商给予买入建议，29%的券商给予持有建议，6%的券商给予卖出建议。 智利矿业化工股票所在的化学制品行业中，整体涨幅为0.39%。其相关个股中，Loop Industries, Inc.、Alto I...
2025-01-07 02:47
BioNexus Gene Lab's Chemrex Announces New Business Developments With $450K Investment In High-Quality Color Paste Specifically Designed For Composite Industrial Customers
BioNexus Gene Lab Corp (NASDAQ:BGLC, the "Company")))), an emerging Biotech & Chemicals company, is pleased to announce that its subsidiary, Chemrex Corporation Sdn. Bhd. (Chemrex), has invested approximately RM 2
2024-09-11 23:07
BioNexus Gene Lab Announce The Successful Co-Investment By The Securities Commission Of Malaysia Into Ascension Innovation Sdn Bhd
BioNexus Gene Lab Corp. (NASDAQ:BGLC), an emerging leader in genomic diagnostics and personalized medicine, is pleased to announce the successful co-investment by the Securities Commission of Malaysia under its Malaysia Co-Investment Fund (MyCIF), into Ascension Innovation Sdn Bhd (AISB). This co-in...
2024-08-27 23:43
BioNexus Gene Lab Shares Rise After Closing Investment in Malaysian Health Tech Firm
01:26 PM EDT, 08/26/2024 (MT Newswires) -- BioNexus Gene Lab (BGLC) shares rose over 4% in recent trading Monday after the company said it closed a 1 million Malaysian ringgit ($229,479) investment in healthcare tech firm Ascension Innovation. The investment, made through BioNexus' subsidiary MRNA S...
2024-08-27 01:26
BioNexus Gene Lab Completes Strategic ~$228K Investment In Ascension Innovation Sdn Bhd; Shares See Volume To The Upside
BioNexus Gene Lab Corp. (NASDAQ:BGLC), an emerging leader in genomic diagnostics and health technology, today announced the successful closing of its RM 1 million (Approx. USD228k) investment in Ascension Innovation Sdn Bhd (AISB), a pioneering Malaysian healthcare technology firm. This strategic in...
2024-08-27 00:20
